Abstract:The envelope E2 glycoprotein of classical swine fever virus (CSFV) is an immunodominant protein which neutralizes the virus. Previous trials to eradicate CSFV have been expensive, inefficient and time-consuming process without complete success. In contrast to DNA transfection into cultured cells, the efficacy of gene transduction in in vivo organ is very low because of the presence of cortical laminar structures and multilayered cells followed by quality and quantity of DNA. Therefore, to eradicate CSFs, developing an effective and inexpensive vaccine targeting E2 glycoprotein is important. Here, we reported using different quantity of DNA with lipofectamine-2000 reagents that could markedly enhance the effectiveness of gene transfer in particular experiment while we are looking for long term development of animal vaccine and an alternative strategy for large scale production of CSFV E2 glycoprotein using baculovirus (bac-to-bac) system in silkworm, Bombyx mori, L. Our results show successful expression of E2 glycoprotein in BmN cell lines and silkworm larvae. The direct injection of recombinant rBacmid/BmNPV/E2 DNA with lipofectamine-2000 reagent infecting the silkworm larvae are varied in different groups and clear symptoms of infection were found and polyhedrons were counted by hemocytometer in individual and different batch. Confocal and electronic microscopy further revealed the expressed polyhedral, followed by SDS-PAGE and western blot further supporting our data. Our study provides an alternative strategy to produce large scale protein against CSFV. Current work to purify the E2 protein for elucidating its structure and development of vaccine is underway.

Prokaryotic Expression of Fdn-Ⅰ,Preparation of Rabbit Anti-Fdn-Ⅰ Antibody and Analysis of the Fdn-Ⅰ Levels in ToMV-Infected Tobacco Leaves

Development of Tobacco necrosis virus A as a vector for efficient and stable expression of FMDV VP1 peptides.

Research Article an Improved Bac-to-Bac/BmNPV Technology Expressing Envelope E2 Glycoprotein of Classical Swine Fever Virus (CSFV) in the Silkworm, Bombyx Mori

Prokaryotic Expression Ofβc1 Gene of DNAβ Satellite Associated with Tobacco Curly Shoot Virus and Preparation of Monoclonal Antibodies Against Its Protein

Monoclonal Antibodies Against Tobacco Rattle Virus And Its Application In The Detection Of Trv Isolates

Expression of Human Interferon Α-2B Gene in Tobacco(Nicotiana Tabacum L.)

Prokaryotic Expression of Full Coat Protein Gene of Tomato Spotted Wilt Virus and Development of Dot-blot ELISA Method for This Virus Detection.

Mutation and Expression Frequency of Fima Gene in Porphyromonas Gingivalis Isolates and Inflammation-Causing Effect of Recombinant Product of the Gene

High expression of foot-and-mouth disease virus structural protein VP1 in tobacco chloroplasts

Prokaryotic Expression of Structural Protein VP1 of Foot-and-mouth disease virus Type O and Analysis of Its Antigenicity

Detection of Foot-and-mouth Virus Antibodies Using a Purified Protein from the High-Level Expression of Codon-Optimized, Foot-and-mouth Disease Virus Complex Epitopes in Escherichia Coli.

Prokaryotic expression of structural domains of the Newcastle disease virus fusion protein and analyses of their antigenic epitopes

Study on the Recombinant Human Interferon α1b, α2b, and Gamma Transient Expression and in Vitro Activities in Tobacco

Engineering of a Single-Chain Variable-Fragment (scFv) Antibody Specific for the Stolbur Phytoplasma (Mollicute) and Its Expression in Escherichia coli and Tobacco Plants

Cloning, Construction of Prokaryotic Expression System and Identification of Vibrio Vulni Ficus Vvha Gene

Development of an Indirect ELISA Based on VP1-CRT Fusion Protein for Detection of FMDV-O in Swine

Expression of Anti-hTERT ScFv in Transgenic Tobacco Plants

Adsorption Purification of TMV Antiserum and Detection Application

High-level expression of codon optimized foot-and-mouth disease virus complex epitopes and cholera toxin B subunit chimera in Hansenula polymorpha.

Transient Expression Vector Construction, Subcellular Localisation, and Evaluation of Antiviral Potential of Flagellin BP8-2

Expression of the Newcastle Disease Virus Fusion Glycoprotein in Vero Cells Using Attenuated Salmonella Typhimurium As Transgenic Carrier